Journal of Pathology Clinical Research

Papers
(The TQCC of Journal of Pathology Clinical Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information48
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach43
Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement43
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma39
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer39
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes34
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements30
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway27
Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma24
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis22
Issue Information22
Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer22
Leveraging deep learning to discover interpretable cellular spatial biomarkers for prognostic predictions based on hepatocellular carcinoma histology20
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy19
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer19
Diffuse glioma with FGFR3‐TACC3 fusion in adults is not a homogenous clinicopathological and molecular entity19
Issue Information18
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer18
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers16
Somatic whole exome sequencing of colorectal carcinoma in young patients from sub‐Saharan Africa reveals novel insights16
15
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study14
14
KRAS mutations and endometriosis burden of disease14
Authors' reply: Re: Koga et al. Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models14
Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation13
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma13
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis13
Engineering the future of 3D pathology12
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis11
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma11
11
Issue Information11
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study11
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression11
Issue Information10
10
Issue Information9
9
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization9
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types8
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer8
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome8
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p8
The ethical challenges of artificial intelligence‐driven digital pathology8
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials8
7
Exosome‐derived ANXA9 functions as an oncogene in breast cancer7
Inter‐rater agreement of HER2‐low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797)7
7
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors7
Issue Information7
Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric aden6
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors6
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior6
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors6
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells6
Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets6
Closing the loop – the role of pathologists in digital and computational pathology research6
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma6
DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics6
Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer6
0.031893968582153